Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors

Article ID	Journal	Published Year	Pages	File Type
8225334	International Journal of Radiation OncologyBiologyPhysics	2012	7 Pages	PDF

Abstract

A volume-adapted dosing approach for SABR of lung tumors seems to provide excellent local control for both small- and large-volume tumors and may reduce toxicity.

Keywords

Biologically effective dose Stereotactic ablative radiotherapy Lung cancer Metastases stereotactic body radiation therapy

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors

Authors

Nicholas M.D., Ph.D., Christine N. B.S., Jeremy B.S., M.Phil., Christopher B.A., Aarti B.A., John B.S., Sean M.D., Edith J. M.D., Heather A. M.D., A. Dimitrios M.D., Richard I. M.D., M.B.A., Sonja Ph.D., Peter G. Ph.D., Dimitre Ph.D., Phuoc M.D., Ph.D.,